Welcome!
Home Covid
Results
Medtecs reports a loss for 1HFY2022 as demand and selling prices drop
The company warns that for the current 2HFY2022, it sees a continued drop in demand.
August 14, 2022
Behind the Bottle
Penfolds’ legendary chief winemaker Peter Gago shares his top tips
Penfolds chief winemaker Peter Gago recommends the best dishes to pair with his wines
January 20, 2022
Covid-19
Three doses of Pfizer-BioNTech vaccine may neutralise Omicron
Initial laboratory studies demonstrate that three doses of the Pfizer-BioNTech Covid-19 Vaccine neutralize the Omicron variant
December 08, 2021
Right Timing
Markets pressured by Covid with HSI heading lower as STI hits support
A Covid mutation in South Africa has unnerved markets, causing the STI to fall to its support, and the HSI to break support
November 26, 2021
Broker's Calls
Deferment of BeerCo IPO may be opportunity to accumulate ThaiBev stocks: Maybank Kim Eng
To Maybank's Chan, the deferment of BeerCo’s IPO is more likely due to a lower-than-expected valuation for the business.
April 21, 2021
Results
Vicplas International reports 2.2 times earnings growth for 1HFY21
Revenue from its medical segment grew 36% on increased customer orders.
March 15, 2021
Property
Millennium & Copthorne New Zealand faces cancellations, unable to forecast exact impact on 1H21 financial performance
The number of deferrals and cancellations vary from hotel to hotel, which will impact M&C New Zealand’s revenue for February.
February 16, 2021
Broker's Calls
PhillipCapital upgrades DBS to 'accumulate' with higher TP of $29.50 on better credit outlook
PhillipCapital has also upped DBS’s FY2021 earnings estimates by 6%, as it lowers allowances of $1 billion.
February 15, 2021
Broker's Calls
Analysts remain positive on UOL Group despite $82.1mil loss in 1H20
CGS-CIMB and DBS Group have maintained a buy rating on UOL Group despite it posting a 1H20 loss of $82.1 million.
August 14, 2020
